TLR2 and necrotizing enterocolitis: Prior studies of neonatal rat models with experimental NEC receiving exogenous treatment of glutamine demonstrated reduced intestinal pathology injury scores and decreased mRNA expression of innate immune receptors toll-like receptor (TLR)-2 and TLR-4 [48].